HomeLPTX • NASDAQ
add
Leap Therapeutics Inc
Previous close
$2.63
Day range
$2.57 - $2.78
Year range
$1.24 - $5.00
Market cap
103.31M USD
Avg Volume
128.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 21.00M | 46.19% |
Net income | -20.36M | -52.07% |
Net profit margin | — | — |
Earnings per share | -0.52 | 42.86% |
EBITDA | -21.00M | -46.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 78.48M | -14.15% |
Total assets | 81.43M | -15.05% |
Total liabilities | 15.64M | 32.53% |
Total equity | 65.79M | — |
Shares outstanding | 38.26M | — |
Price to book | 1.53 | — |
Return on assets | -75.32% | — |
Return on capital | -91.92% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -20.36M | -52.07% |
Cash from operations | -13.67M | -34.23% |
Cash from investing | — | — |
Cash from financing | 37.12M | — |
Net change in cash | 23.56M | 321.76% |
Free cash flow | -6.55M | -0.44% |
About
Founded
2011
Website
Employees
54
